Dolutegravir-Based Regimen for Maintenance of Viral Suppression in People Living with HIV: 48-Week Results in Real-Life SettingDaniele Di Carlo, Ombretta Turriziani, Enrico Palermo et al.|AIDS Research and Human Retroviruses|2021Cited by 11